{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:35:25Z","timestamp":1790620525199,"version":"4.1.0"},"reference-count":184,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T00:00:00Z","timestamp":1594425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Chronic pulmonary aspergillosis (CPA) refers to a spectrum of Aspergillus-mediated disease that is associated with high morbidity and mortality, with its true prevalence vastly underestimated. The diagnosis of CPA includes characteristic radiographical findings in conjunction with persistent and systemic symptoms present for at least three months, and evidence of Aspergillus infection. Traditionally, Aspergillus infection has been confirmed through histopathology and microbiological studies, including fungal culture and serology, but these methodologies have limitations that are discussed in this review. The treatment of CPA requires an individualized approach and consideration of both medical and surgical options. Most Aspergillus species are considered susceptible to mold-active triazoles, echinocandins, and amphotericin B; however, antifungal resistance is emerging and well documented, demonstrating the need for novel therapies and antifungal susceptibility testing that correlates with clinical response. Here, we describe the clinical presentation, diagnosis, and treatment of CPA, with an emphasis on the strengths and pitfalls of diagnostic and treatment approaches, as well as future directions, including whole genome sequencing and metagenomic sequencing. The advancement of molecular technology enables rapid and precise species level identification, and the determination of molecular mechanisms of resistance, bridging the clinical infectious disease, anatomical pathology, microbiology, and molecular biology disciplines.<\/jats:p>","DOI":"10.3390\/jof6030106","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T04:46:01Z","timestamp":1594701961000},"page":"106","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A Collaborative Tale of Diagnosing and Treating Chronic Pulmonary Aspergillosis, from the Perspectives of Clinical Microbiologists, Surgical Pathologists, and Infectious Disease Clinicians"],"prefix":"10.3390","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8371-584X","authenticated-orcid":false,"given":"Paige M. K.","family":"Larkin","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA"},{"name":"Department of Pathology, NorthShore University HealthSystem, Evanston, IL 60201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4043-4287","authenticated-orcid":false,"given":"Ashrit","family":"Multani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of California Los Angeles, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer E.","family":"Beaird","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of California Los Angeles, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayrton J.","family":"Dayo","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3632-5654","authenticated-orcid":false,"given":"Gregory A.","family":"Fishbein","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9991-1178","authenticated-orcid":false,"given":"Shangxin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrmicro.2017.90","article-title":"Aspergillus fumigatus morphology and dynamic host interactions","volume":"15","author":"Gresnigt","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1007\/s00330-015-3690-7","article-title":"Chronic Aspergillosis of the Lungs: Unravelling the Terminology and Radiology","volume":"25","author":"Desai","year":"2015","journal-title":"Eur. Radiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/1751-7915.12367","article-title":"Ecology of aspergillosis: Insights into the pathogenic potency of Aspergillus fumigatus and some other Aspergillus species","volume":"10","author":"Paulussen","year":"2016","journal-title":"Microb. Biotechnol."},{"key":"ref_4","first-page":"33","article-title":"Aspergillus fumigatus and Aspergillosis in 2019","volume":"33","author":"Chamilos","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1086\/376526","article-title":"Chronic Cavitary and Fibrosing Pulmonary and Pleural Aspergillosis: Case Series, Proposed Nomenclature Change, and Review","volume":"37","author":"Denning","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1183\/09031936.00054810","article-title":"Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma","volume":"37","author":"Smith","year":"2010","journal-title":"Eur. Respir. J."},{"key":"ref_7","first-page":"1","article-title":"Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives","volume":"96","author":"Cadranel","year":"2018","journal-title":"Respiration"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s40265-017-0714-4","article-title":"Triazole Resistance in Aspergillus Species: An Emerging Problem","volume":"77","author":"Mellado","year":"2017","journal-title":"Drugs"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3201\/eid2601.190885","article-title":"High Azole Resistance in Aspergillus fumigatus Isolates from Strawberry Fields, China, 2018","volume":"26","author":"Chen","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.idc.2015.10.015","article-title":"Invasive aspergillosis: Current strategies for diagnosis and management","volume":"30","author":"Cadena","year":"2016","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hayes, G.E., and Novak-Frazer, L. (2016). Chronic Pulmonary Aspergillosis\u2014Where Are We? and Where Are We Going?. J. Fungi, 2.","DOI":"10.3390\/jof2020018"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: Rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jinf.2015.11.003","article-title":"Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA)","volume":"72","author":"Page","year":"2016","journal-title":"J. Infect."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1067\/mai.2001.119570","article-title":"Hypersensitivity pneumonitis: Current concepts and future questions","volume":"108","author":"Patel","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_16","first-page":"497","article-title":"Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi","volume":"111","author":"Katzenstein","year":"1975","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0046-8177(97)90173-8","article-title":"The histological spectrum of chronic necrotizing forms of pulmonary aspergillosis","volume":"28","author":"Yousem","year":"1997","journal-title":"Hum. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.00053-10","article-title":"Histopathologic Diagnosis of Fungal Infections in the 21st Century","volume":"24","author":"Guarner","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-3-540-29676-8_3239","article-title":"Aspergillosis","volume":"Volume 2","author":"Scharnagl","year":"2009","journal-title":"Encyclopedia of Molecular Mechanisms of Disease"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1093\/mmy\/myy103","article-title":"How to make a fast diagnosis in invasive aspergillosis","volume":"57","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1053\/j.semdp.2017.06.002","article-title":"Histopathology of fungal diseases of the lung","volume":"34","author":"Roden","year":"2017","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3109\/13693780903512835","article-title":"Discrepancy between histology and culture in filamentous fungal infections","volume":"48","author":"Lee","year":"2010","journal-title":"Med. Mycol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fmicb.2018.01810","article-title":"Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis","volume":"9","author":"Takazono","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Walsh, T.J., Hayden, R., and Larone, D.H. (2018). Larone\u2019s Medically Important Fungi: A Guide to Identification, American Society for Microbiology.","DOI":"10.1128\/9781555819880"},{"key":"ref_25","unstructured":"St Germain, G., and Summerbell, R. (2010). Identifying Fungi, Star Pubs & Bars Limited Co.. [2nd ed.]."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/CMR.12.2.310","article-title":"Aspergillus fumigatus and Aspergillosis","volume":"12","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e01353-17","DOI":"10.1128\/JCM.01353-17","article-title":"Multicenter Evaluation of the Vitek MS v3.0 System for the Identification of Filamentous Fungi","volume":"56","author":"Rychert","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1469-0691.2011.03599.x","article-title":"Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry","volume":"18","author":"Posteraro","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/myc.12800","article-title":"Evaluation of three MALDI-TOF mass spectrometry libraries for the identification of filamentous fungi in three clinical microbiology laboratories in Manitoba, Canada","volume":"61","author":"Stein","year":"2018","journal-title":"Mycoses"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.3389\/fmicb.2019.02098","article-title":"Multicenter Study Demonstrates Standardization Requirements for Mold Identification by MALDI-TOF MS","volume":"10","author":"Lau","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/JCM.01640-16","article-title":"Identification of Molds by Matrix-Assisted Laser Desorption Ionization\u2013Time of Flight Mass Spectrometry","volume":"55","author":"Sanguinetti","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/mmy\/myu064","article-title":"Identification of filamentous fungi isolates by MALDI-TOF mass spectrometry: Clinical evaluation of an extended reference spectra library","volume":"52","author":"Becker","year":"2014","journal-title":"Med. Mycol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/JCM.03258-13","article-title":"Misidentification of Aspergillus nomius and Aspergillus tamarii as Aspergillus flavus: Characterization by Internal Transcribed Spacer, -Tubulin, and Calmodulin Gene Sequencing, Metabolic Fingerprinting, and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry","volume":"52","author":"Tam","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Normand, A.-C., Cassagne, C., Gautier, M., Becker, P., Ranque, S., Hendrickx, M., and Piarroux, R. (2017). Decision criteria for MALDI-TOF MS-based identification of filamentous fungi using commercial and in-house reference databases. BMC Microbiol., 17.","DOI":"10.1186\/s12866-017-0937-2"},{"key":"ref_35","first-page":"838","article-title":"Identification of clinical isolates of Aspergillus, including cryptic species, by matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS)","volume":"56","author":"Aznar","year":"2017","journal-title":"Med. Mycol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jix210","article-title":"Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment","volume":"216","author":"Chowdhary","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure1","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1128\/AAC.00517-11","article-title":"Interrogation of Related Clinical Pan-Azole-Resistant Aspergillus fumigatus Strains: G138C, Y431C, and G434C Single Nucleotide Polymorphisms in cyp51A, Upregulation of cyp51A, and Integration and Activation of Transposon Atf1 in the cyp51A Promoter","volume":"55","author":"Albarrag","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1086\/342384","article-title":"Has Antifungal Susceptibility Testing Come of Age?","volume":"35","author":"Rex","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/13693780701436794","article-title":"Current status of antifungal susceptibility testing methods","volume":"45","author":"Arikan","year":"2007","journal-title":"Med. Mycol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e01634-18","DOI":"10.1128\/AAC.01634-18","article-title":"Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials","volume":"63","author":"Andes","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.3109\/13693786.2010.508469","article-title":"Acquired antifungal drug resistance in Aspergillus fumigatus: Epidemiology and detection","volume":"49","author":"Howard","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e00168-17","DOI":"10.1128\/AAC.00168-17","article-title":"Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method","volume":"61","author":"Mello","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e00780-18","DOI":"10.1128\/JCM.00780-18","article-title":"Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species","volume":"56","author":"Wang","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1128\/JCM.41.3.1126-1129.2003","article-title":"In Vitro Susceptibility Testing of Aspergillus spp.: Comparison of Etest and Reference Microdilution Methods for Determining Voriconazole and Itraconazole MICs","volume":"41","author":"Pfaller","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1128\/JCM.01475-15","article-title":"Evaluation of a Quantitative Serological Assay for Diagnosing Chronic Pulmonary Aspergillosis","volume":"54","author":"Fujiuchi","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/myc.12765","article-title":"Diagnostic value of serum galactomannan, (1,3)-\u03b2-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients","volume":"61","author":"Dobias","year":"2018","journal-title":"Mycoses"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/myc.12541","article-title":"Role of Aspergillus fumigatus -specific IgG in diagnosis and monitoring treatment response in allergic bronchopulmonary aspergillosis","volume":"60","author":"Agarwal","year":"2016","journal-title":"Mycoses"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.alit.2018.04.009","article-title":"Concordance between Aspergillus-specific precipitating antibody and IgG in allergic bronchopulmonary aspergillosis","volume":"67","author":"Harada","year":"2018","journal-title":"Allergol. Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.15.3.465-484.2002","article-title":"Current Status of Nonculture Methods for Diagnosis of Invasive Fungal Infections","volume":"15","author":"Yeo","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jinf.2014.04.008","article-title":"The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections","volume":"69","author":"Rose","year":"2014","journal-title":"J. Infect."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s15010-015-0849-8","article-title":"Evaluation of serum (1 \u2192 3)-\u03b2-d-glucan clinical performance: Kinetic assessment, comparison with galactomannan and evaluation of confounding factors","volume":"44","author":"Pini","year":"2015","journal-title":"Infection"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1128\/JCM.02091-07","article-title":"Contribution of the (1->3)- -D-Glucan Assay for Diagnosis of Invasive Fungal Infections","volume":"46","author":"Persat","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/JCM.02497-16","article-title":"Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and \u03b2-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis","volume":"55","author":"Urabe","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s10096-011-1244-8","article-title":"Reactivity of (1 \u2192 3)-\u03b2-d-glucan assay in bacterial bloodstream infections","volume":"30","author":"Albert","year":"2011","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jinf.2015.09.016","article-title":"Prognostic potential of 1,3-beta-d-glucan levels in bronchoalveolar lavage fluid samples","volume":"72","author":"Reischies","year":"2016","journal-title":"J. Infect."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1128\/JCM.03567-13","article-title":"Use and Limits of (1-3)- -D-Glucan Assay (Fungitell), Compared to Galactomannan Determination (Platelia Aspergillus), for Diagnosis of Invasive Aspergillosis","volume":"52","author":"Sulahian","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1399-3062.2003.00031.x","article-title":"Rapid diagnosis of invasive aspergillosis by antigen detection","volume":"5","author":"Wheat","year":"2003","journal-title":"Transpl. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1055\/s-0035-1562892","article-title":"Role of Non-Culture-Based Tests, with an Emphasis on Galactomannan Testing for the Diagnosis of Invasive Aspergillosis","volume":"36","author":"Maertens","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/JCM.00506-08","article-title":"Utility of Galactomannan Enzyme Immunoassay and (1,3) -D-Glucan in Diagnosis of Invasive Fungal Infections: Low Sensitivity for Aspergillus fumigatus Infection in Hematologic Malignancy Patients","volume":"47","author":"Hachem","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1200\/JCO.2002.07.004","article-title":"AspergillusGalactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer Patients","volume":"20","author":"Herbrecht","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1439-0507.1998.tb00356.x","article-title":"False-positive results in premature infants with the Platelia\u00aeAspergillussandwich enzyme-linked immunosorbent assay","volume":"41","author":"Siemann","year":"1998","journal-title":"Mycoses"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1128\/JCM.43.8.3925-3931.2005","article-title":"Bifidobacterial Lipoglycan as a New Cause for False-Positive Platelia Aspergillus Enzyme-Linked Immunosorbent Assay Reactivity","volume":"43","author":"Ruegebrink","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1086\/382224","article-title":"False-Positive Galactomannan PlateliaAspergillusTest Results for Patients Receiving Piperacillin-Tazobactam","volume":"38","author":"Viscoli","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Liu, W.-D., Lin, S.-W., Shih, M.-C., Su, C.-L., Wang, Y.-W., Lee, Y.-F., Huang, H.-H., Chou, W.-C., Wu, U.-I., and Chen, Y.-C. (2020). False-positive Aspergillus galactomannan immunoassays associated with intravenous human immunoglobulin administration. Clin. Microbiol. Infect.","DOI":"10.1016\/j.cmi.2020.02.002"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1128\/JCM.42.11.5362-5363.2004","article-title":"False-Positive Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay Results In Vivo during Amoxicillin-Clavulanic Acid Treatment","volume":"42","author":"Mattei","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/JCM.43.6.2929-2931.2005","article-title":"Cryptococcus neoformans Galactoxylomannan Contains an Epitope(s) That Is Cross-Reactive with Aspergillus Galactomannan","volume":"43","author":"Dalle","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s15010-010-0003-6","article-title":"The interaction between piperacillin\/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-d-glucan in patients without risk factors for invasive fungal infections","volume":"38","author":"Metan","year":"2010","journal-title":"Infection"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1128\/JCM.03322-12","article-title":"Multicenter Comparison of Serum and Whole-Blood Specimens for Detection of Aspergillus DNA in High-Risk Hematological Patients","volume":"51","author":"Springer","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1093\/mmy\/myx091","article-title":"Diagnosis of aspergillosis by PCR: Clinical considerations and technical tips","volume":"56","author":"Barnes","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_71","first-page":"402","article-title":"Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus ?","volume":"55","author":"Morton","year":"2016","journal-title":"Med. Mycol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/mmy\/myw080","article-title":"Performance evaluation of multiplex PCR including Aspergillus\u2014Not so simple!","volume":"55","author":"Alanio","year":"2016","journal-title":"Med. Mycol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/cid\/civ507","article-title":"Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison with Antigen Testing","volume":"61","author":"White","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JCM.40.6.2224-2227.2002","article-title":"Real-Time PCR Coupled with Automated DNA Extraction and Detection of Galactomannan Antigen in Serum by Enzyme-Linked Immunosorbent Assay for Diagnosis of Invasive Aspergillosis","volume":"40","author":"Costa","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"ref_75","first-page":"528","article-title":"Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis","volume":"55","author":"Eigl","year":"2016","journal-title":"Med. Mycol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1128\/JCM.01580-16","article-title":"New Panfungal Real-Time PCR Assay for Diagnosis of Invasive Fungal Infections","volume":"54","author":"Valero","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Rickerts, V., Khot, P.D., Myerson, D., Ko, D.L., Lambrecht, E., and Fredricks, D.N. (2011). Comparison of quantitative real time PCR with Sequencing and ribosomal RNA-FISH for the identification of fungi in Formalin fixed, paraffin-embedded tissue specimens. BMC Infect. Dis., 11.","DOI":"10.1186\/1471-2334-11-202"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/JCM.00459-10","article-title":"Improving Molecular Detection of Fungal DNA in Formalin-Fixed Paraffin-Embedded Tissues: Comparison of Five Tissue DNA Extraction Methods Using Panfungal PCR","volume":"48","author":"Rudd","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1128\/JCM.01862-06","article-title":"Development and Clinical Application of a Panfungal PCR Assay to Detect and Identify Fungal DNA in Tissue Specimens","volume":"45","author":"Lau","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1073\/pnas.1117018109","article-title":"Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi","volume":"109","author":"Schoch","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1128\/JCM.43.5.2092-2103.2005","article-title":"Assessment of Ribosomal Large-Subunit D1-D2, Internal Transcribed Spacer 1, and Internal Transcribed Spacer 2 Regions as Targets for Molecular Identification of Medically Important Aspergillus Species","volume":"43","author":"Hinrikson","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/13693786.2010.525537","article-title":"Degradation of fungal DNA in formalin-fixed paraffin-embedded sinus fungal balls hampers reliable sequence-based identification of fungi","volume":"49","author":"Cabaret","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Flury, B.B., Weisser, M., Prince, S.S., Bubendorf, L., Battegay, M., Frei, R., and Goldenberger, D. (2014). Performances of two different panfungal PCRs to detect mould DNA in formalin-fixed paraffin-embedded tissue: What are the limiting factors?. BMC Infect. Dis., 14.","DOI":"10.1186\/s12879-014-0692-z"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1373\/jalm.2018.026120","article-title":"Metagenomics to Assist in the Diagnosis of Bloodstream Infection","volume":"3","author":"Greninger","year":"2019","journal-title":"J. Appl. Lab. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41564-018-0349-6","article-title":"Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease","volume":"4","author":"Blauwkamp","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa1803396","article-title":"Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis","volume":"380","author":"Wilson","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"776","DOI":"10.5858\/arpa.2016-0539-RA","article-title":"Validation of Metagenomic Next-Generation Sequencing Tests for Universal Pathogen Detection","volume":"141","author":"Schlaberg","year":"2017","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e27734","DOI":"10.1002\/pbc.27734","article-title":"Cell-free DNA next-generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease","volume":"66","author":"Armstrong","year":"2019","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fcimb.2018.00375","article-title":"Limited Correlation of Shotgun Metagenomics Following Host Depletion and Routine Diagnostics for Viruses and Bacteria in Low Concentrated Surrogate and Clinical Samples","volume":"8","author":"Oechslin","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/5584_2016_42","article-title":"Sensitivity of Next-Generation Sequencing Metagenomic Analysis for Detection of RNA and DNA Viruses in Cerebrospinal Fluid: The Confounding Effect of Background Contamination","volume":"944","author":"Perlejewski","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_91","first-page":"89","article-title":"Metagenomic Analysis of Cerebrospinal Fluid from Patients with Multiple Sclerosis","volume":"935","author":"Perlejewski","year":"2016","journal-title":"Plant Promot. Transcr. Factors"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1128\/JCM.00273-11","article-title":"Unbiased Parallel Detection of Viral Pathogens in Clinical Samples by Use of a Metagenomic Approach","volume":"49","author":"Yang","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/JCM.03050-15","article-title":"Depletion of Human DNA in Spiked Clinical Specimens for Improvement of Sensitivity of Pathogen Detection by Next-Generation Sequencing","volume":"54","author":"Hasan","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/cid\/ciy303","article-title":"Identification of Prosthetic Joint Infection Pathogens Using a Shotgun Metagenomics Approach","volume":"67","author":"Thoendel","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Laurence, M., Hatzis, C., and Brash, D.E. (2014). Common Contaminants in Next-Generation Sequencing That Hinder Discovery of Low-Abundance Microbes. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0097876"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3389\/fmicb.2017.01069","article-title":"Metagenomics: The Next Culture-Independent Game Changer","volume":"8","author":"Forbes","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Frickmann, H., Kuenne, C., Hagen, R.M., Podbielski, A., Normann, J., Poppert, S., Looso, M., and Kreikemeyer, B. (2019). Next-generation sequencing for hypothesis-free genomic detection of invasive tropical infections in poly-microbially contaminated, formalin-fixed, paraffin-embedded tissue samples\u2014A proof-of-principle assessment. BMC Microbiol., 19.","DOI":"10.1186\/s12866-019-1448-0"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e01888-15","DOI":"10.1128\/mBio.01888-15","article-title":"Making the Leap from Research Laboratory to Clinic: Challenges and Opportunities for Next-Generation Sequencing in Infectious Disease Diagnostics","volume":"6","author":"Goldberg","year":"2015","journal-title":"mBio"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses","volume":"64","author":"Lockhart","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_100","first-page":"15","article-title":"Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance","volume":"68","author":"Escandon","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/jac\/dkx480","article-title":"A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009\u201317) in India: Role of the ERG11 and FKS1 genes in azole and echinocandin resistance","volume":"73","author":"Chowdhary","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/s41588-018-0246-1","article-title":"Investigation of inter- and intraspecies variation through genome sequencing of Aspergillus section Nigri","volume":"50","author":"Vesth","year":"2018","journal-title":"Nat. Genet."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11046-020-00433-0","article-title":"Whole-Genome Sequencing of Aspergillus terreus Species Complex","volume":"185","author":"Palanivel","year":"2020","journal-title":"Mycopathologia"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/mmy\/myv003","article-title":"Genome sequence comparison of Aspergillus fumigatus strains isolated from patients with pulmonary aspergilloma and chronic necrotizing pulmonary aspergillosis","volume":"53","author":"Muraosa","year":"2015","journal-title":"Med. Mycol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e00536-15","DOI":"10.1128\/mBio.00536-15","article-title":"Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing","volume":"6","author":"Abdolrasouli","year":"2015","journal-title":"mBio"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.01092-06","article-title":"A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A Alterations","volume":"51","author":"Mellado","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/myc.12354","article-title":"Azole-resistant Aspergillus fumigatus isolates carrying TR34\/L98H mutations in Taiwan","volume":"58","author":"Wu","year":"2015","journal-title":"Mycoses"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/myc.12702","article-title":"PCR-based detection ofAspergillus fumigatusand absence of azole resistance due to TR34\/L98H in a french multicenter cohort of 137 patients with fungal rhinosinusitis","volume":"61","author":"Morio","year":"2017","journal-title":"Mycoses"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/AAC.04469-14","article-title":"The Strength of Synergistic Interaction between Posaconazole and Caspofungin Depends on the Underlying Azole Resistance Mechanism of Aspergillus fumigatus","volume":"59","author":"Mavridou","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1128\/JCM.01105-14","article-title":"Whole-Genome Comparison of Aspergillus fumigatus Strains Serially Isolated from Patients with Aspergillosis","volume":"52","author":"Hagiwara","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e00085-19","DOI":"10.1128\/mSystems.00085-19","article-title":"Resistance Gene-Directed Genome Mining of 50 Aspergillus Species","volume":"4","author":"Vesth","year":"2019","journal-title":"mSystems"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Garcia-Rubio, R., Monz\u00f3n, S., Alcazar-Fuoli, L., Cuesta, I., and Mellado, E. (2018). Genome-Wide Comparative Analysis of Aspergillus fumigatus Strains: The Reference Genome as a Matter of Concern. Genes, 9.","DOI":"10.3390\/genes9070363"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/JCM.37.5.1606-1609.1999","article-title":"Invasive Aspergillosis Caused by Aspergillus ustus: Case Report and Review","volume":"37","author":"Verweij","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3201\/eid1203.050670","article-title":"Aspergillus ustus Infections among Transplant Recipients","volume":"12","author":"Panackal","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/myc.12075","article-title":"Itraconazole in chronic cavitary pulmonary aspergillosis: A randomised controlled trial and systematic review of literature","volume":"56","author":"Agarwal","year":"2013","journal-title":"Mycoses"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1439-0507.1988.tb03653.x","article-title":"The Treatment of Aspergillosis and Aspergilloma with Itraconazole, Clinical Results of an Open International Study (1982\u20131987)\/Die Behandlung der Aspergillose und des Aspergilloms mit Itraconazol, Klinische Ergebnisse einer offenen internationalen Studi","volume":"31","author":"Beule","year":"2009","journal-title":"Mycoses"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.jinf.2005.08.022","article-title":"The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis","volume":"52","author":"Jain","year":"2006","journal-title":"J. Infect."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"527.e17","DOI":"10.1016\/j.amjmed.2005.11.028","article-title":"Voriconazole Treatment for Subacute Invasive and Chronic Pulmonary Aspergillosis","volume":"119","author":"Sambatakou","year":"2006","journal-title":"Am. J. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s15010-012-0322-x","article-title":"Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: Experience in Japan","volume":"40","author":"Saito","year":"2012","journal-title":"Infection"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s15010-014-0711-4","article-title":"Treatment of chronic pulmonary aspergillosis with voriconazole: Review of a case series","volume":"43","author":"Cucchetto","year":"2014","journal-title":"Infection"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/myc.12885","article-title":"Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events","volume":"62","author":"Bongomin","year":"2019","journal-title":"Mycoses"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1592\/phco.19.8.603.31529","article-title":"Itraconazole in Cyclodextrin Solution","volume":"19","author":"Stevens","year":"1999","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1128\/AAC.00973-15","article-title":"Population Pharmacokinetic Modeling of Itraconazole and Hydroxyitraconazole for Oral SUBA-Itraconazole and Sporanox Capsule Formulations in Healthy Subjects in Fed and Fasted States","volume":"59","author":"Abuhelwa","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_124","first-page":"835","article-title":"Selection of oral antifungals for initial maintenance therapy in chronic pulmonary aspergillosis: A longitudinal analysis","volume":"70","author":"Tashiro","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/ctr.12834","article-title":"Adverse effects of voriconazole: Over a decade of use","volume":"30","author":"Levine","year":"2016","journal-title":"Clin. Transplant."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e13130","DOI":"10.1111\/tid.13130","article-title":"When medicine transforms art","volume":"21","author":"Belga","year":"2019","journal-title":"Transpl. Infect. Dis."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1056\/NEJMicm1814565","article-title":"Voriconazole-Induced Periostitis","volume":"381","author":"Hedrick","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1128\/AAC.01221-08","article-title":"Accelerated Metabolism of Voriconazole and Its Partial Reversal by Cimetidine","volume":"53","author":"Moriyama","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/657306","article-title":"Efficacy and Safety of Posaconazole for Chronic Pulmonary Aspergillosis","volume":"51","author":"Felton","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijantimicag.2018.06.001","article-title":"Assessment of posaconazole salvage therapy in chronic pulmonary aspergillosis using predefined response criteria","volume":"52","author":"Harris","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/cid\/cit411","article-title":"Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: A longitudinal analysis","volume":"57","author":"Atherton","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/jac\/dky539","article-title":"Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis","volume":"74","author":"Kosmidis","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12281-016-0255-4","article-title":"Therapeutic Drug Monitoring of Posaconazole: An Update","volume":"10","author":"Dekkers","year":"2016","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/myc.12452","article-title":"Comparison of posaconazole serum concentrations from haematological cancer patients on posaconazole tablet and oral suspension for treatment and prevention of invasive fungal infections","volume":"59","author":"Pham","year":"2016","journal-title":"Mycoses"},{"key":"ref_135","first-page":"1","article-title":"Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections","volume":"8","author":"Wiederhold","year":"2015","journal-title":"Clin. Pharmacol. Adv. Appl."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"459","DOI":"10.18176\/jiaci.0424","article-title":"Successful Treatment of Chronic Pulmonary Aspergillosis with Isavuconazole","volume":"29","author":"Corbella","year":"2019","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): A phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2147\/TCRM.S90335","article-title":"Role of isavuconazole in the treatment of invasive fungal infections","volume":"12","author":"Wilson","year":"2016","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jinf.2010.08.005","article-title":"Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: A multicenter trial in Japan","volume":"61","author":"Kohno","year":"2010","journal-title":"J. Infect."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/crj.13171","article-title":"Pulsed echinocandin therapy in azole intolerant or multiresistant chronic pulmonary aspergillosis: A retrospective review at a UK tertiary centre","volume":"14","author":"Osborne","year":"2020","journal-title":"Clin. Respir. J."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/thoraxjnl-2013-203988","article-title":"Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis","volume":"69","author":"Keir","year":"2013","journal-title":"Thorax"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10096-012-1754-z","article-title":"A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis","volume":"32","author":"Kohno","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4065\/mcp.2011.0247","article-title":"Current Concepts in Antifungal Pharmacology","volume":"86","author":"Lewis","year":"2011","journal-title":"Mayo Clin. Proc."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jinf.2016.06.001","article-title":"Impact of liposomal amphotericin B therapy on chronic pulmonary aspergillosis","volume":"73","author":"Newton","year":"2016","journal-title":"J. Infect."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/j.ijid.2009.07.011","article-title":"Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: A review of 43 cases","volume":"14","author":"Nam","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/cid\/ciu581","article-title":"Antifungal Combination Therapy for Invasive Aspergillosis","volume":"59","author":"Espigado","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Steinbach, W.J., Stevens, D.A., and Denning, D.W. (2003). Combination and Sequential Antifungal Therapy for Invasive Aspergillosis: Review of Published In Vitro and In Vivo Interactions and 6281 Clinical Cases from 1966 to 2001. Clin. Infect. Dis., 37.","DOI":"10.1086\/376524"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/thx.51.3.253","article-title":"Topical treatment of life threatening haemoptysis from aspergillomas","volume":"51","author":"Rumbak","year":"1996","journal-title":"Thorax"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.12-1784","article-title":"A Modern Series of Percutaneous Intracavitary Instillation of Amphotericin B for the Treatment of Severe Hemoptysis from Pulmonary Aspergilloma","volume":"143","author":"Kravitz","year":"2013","journal-title":"Chest"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0720-048X(97)00148-4","article-title":"CT-guided percutaneous treatment of inoperable pulmonary aspergillomas: A study of 40 cases","volume":"28","author":"Giron","year":"1998","journal-title":"Eur. J. Radiol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1378\/chest.103.5.1421","article-title":"Topical Treatment of Pulmonary Aspergilloma by Antifungals","volume":"103","author":"Yamada","year":"1993","journal-title":"Chest"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0002-9343(80)90109-6","article-title":"Intracavitary amphotericin B in the treatment of symptomatic pulmonary aspergillomas","volume":"68","author":"Hargis","year":"1980","journal-title":"Am. J. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2214\/ajr.161.4.8372746","article-title":"Treatment of hemoptysis in patients with cavitary aspergilloma of the lung: Value of percutaneous instillation of amphotericin B","volume":"161","author":"Lee","year":"1993","journal-title":"Am. J. Roentgenol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1148\/radiology.188.3.8351355","article-title":"Intracavitary aspergilloma: Transthoracic percutaneous injection of amphotericin gelatin solution","volume":"188","author":"Munk","year":"1993","journal-title":"Radiology"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/thx.48.9.928","article-title":"Treatment of symptomatic pulmonary aspergillomas with intracavitary instillation of amphotericin B through an indwelling catheter","volume":"48","author":"Jackson","year":"1993","journal-title":"Thorax"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0041-3879(70)90071-1","article-title":"Local treatment of aspergilloma of the lung with a paste containing nystatin or amphotericin B","volume":"51","author":"Krakowka","year":"1970","journal-title":"Tubercle"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"S474","DOI":"10.1093\/infdis\/jix130","article-title":"Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi","volume":"216","author":"McCarthy","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_158","first-page":"287","article-title":"Novel approaches to antifungal therapy","volume":"18","author":"Thompson","year":"2018","journal-title":"Arab. Archaeol. Epigr."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.1073\/pnas.1608304113","article-title":"F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase","volume":"113","author":"Oliver","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijantimicag.2017.09.002","article-title":"The antifungal arsenal: Alternative drugs and future targets","volume":"51","author":"Wiederhold","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_161","first-page":"AAC.0023-18","article-title":"Effect of the Novel Antifungal Drug F901318 (Olorofim) on Growth and Viability ofAspergillus fumigatus","volume":"62","author":"Beckmann","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"ofaa016","DOI":"10.1093\/ofid\/ofaa016","article-title":"Hope on the Horizon: Novel Fungal Treatments in Development","volume":"7","author":"Rauseo","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/thx.38.8.579","article-title":"What happens to patients with pulmonary aspergilloma? Analysis of 23 cases","volume":"38","author":"Rafferty","year":"1983","journal-title":"Thorax"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/thorax.55.8.717","article-title":"Non-tuberculous mycobacterial lung infection complicated by chronic necrotising pulmonary aspergillosis","volume":"55","author":"Hafeez","year":"2000","journal-title":"Thorax"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1183\/09031936.06.00021705","article-title":"Interferon- therapy in two patients with progressive chronic pulmonary aspergillosis","volume":"27","author":"Kelleher","year":"2006","journal-title":"Eur. Respir. J."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/thoraxjnl-2019-213606","article-title":"Interferon gamma replacement as salvage therapy in chronic pulmonary aspergillosis: Effects on frequency of acute exacerbation and all-cause hospital admission","volume":"75","author":"Monk","year":"2020","journal-title":"Thorax"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/S1473-3099(17)30442-5","article-title":"Immunotherapeutic approaches to treatment of fungal diseases","volume":"17","author":"Brown","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/mmy\/myw060","article-title":"The anti-Aspergillusdrug pipeline: Is the glass half full or empty?","volume":"55","author":"Osherov","year":"2016","journal-title":"Med Mycol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fimmu.2017.01939","article-title":"Methods of Controlling Invasive Fungal Infections Using CD8+ T Cells","volume":"8","author":"Kumaresan","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Prutsky, G., Salazar, C., and Accinelli, R. (2012). Antifibrinolytic therapy to reduce haemoptysis from any cause. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD008711.pub2"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/icvts\/ivt383","article-title":"Does tranexamic acid stop haemoptysis?","volume":"17","author":"Moen","year":"2013","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.2169\/internalmedicine.0553-17","article-title":"Successful Long-term Management of Two Cases of Moderate Hemoptysis Due to Chronic Cavitary Pulmonary Aspergillosis with Bronchial Occlusion Using Silicone Spigots","volume":"57","author":"Oda","year":"2018","journal-title":"Intern. Med."},{"key":"ref_173","first-page":"3671","article-title":"Clinical profile and surgical outcome for different types of chronic pulmonary aspergillosis","volume":"11","author":"He","year":"2019","journal-title":"Am. J. Transl. Res"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.athoracsur.2013.10.050","article-title":"Surgical Therapy of Pulmonary Aspergillomas: A 30-Year North American Experience","volume":"97","author":"Muniappan","year":"2014","journal-title":"Ann. Thorac. Surg."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.athoracsur.2004.05.050","article-title":"Good Long-Term Outcomes After Surgical Treatment of Simple and Complex Pulmonary Aspergilloma","volume":"79","author":"Kim","year":"2005","journal-title":"Ann. Thorac. Surg."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.athoracsur.2005.03.078","article-title":"Clinical Profile and Surgical Outcome for Pulmonary Aspergilloma: A Single Center Experience","volume":"80","author":"Akbari","year":"2005","journal-title":"Ann. Thorac. Surg."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1749-8090-8-180","article-title":"Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence-a National Centre\u2019s experience","volume":"8","author":"Farid","year":"2013","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Setianingrum, F., Rautemaa-Richardson, R., Shah, R., and Denning, D.W. (2020). Clinical outcomes of patients with chronic pulmonary aspergillosis managed surgically. Eur. J. Cardio-Thorac. Surg.","DOI":"10.1093\/ejcts\/ezaa137"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.athoracsur.2013.08.010","article-title":"Video-Assisted Thoracic Surgery for Pulmonary Aspergilloma: A Safe and Effective Procedure","volume":"97","author":"Chen","year":"2014","journal-title":"Ann. Thorac. Surg."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jiac.2014.02.003","article-title":"Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance treatment by antifungal triazoles","volume":"20","author":"Koyama","year":"2014","journal-title":"J. Infect. Chemother."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1601062","DOI":"10.1183\/13993003.01062-2016","article-title":"Predictors of mortality in chronic pulmonary aspergillosis","volume":"49","author":"Lowes","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.rmed.2012.01.014","article-title":"Clinical characteristics and prognosis of chronic pulmonary aspergillosis","volume":"106","author":"Ohba","year":"2012","journal-title":"Respir. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/myc.12950","article-title":"Chronic pulmonary aspergillosis in a tertiary care centre in Spain: A retrospective, observational study","volume":"62","author":"Goterris","year":"2019","journal-title":"Mycoses"},{"key":"ref_184","first-page":"1","article-title":"Chronic fibrosing pulmonary aspergillosis: A cause of \u2018destroyed lung\u2019 syndrome","volume":"49","author":"Kosmidis","year":"2016","journal-title":"Infect. Dis."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/6\/3\/106\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:50:17Z","timestamp":1760176217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/6\/3\/106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,11]]},"references-count":184,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["jof6030106"],"URL":"https:\/\/doi.org\/10.3390\/jof6030106","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,11]]}}}